Education
About Us
Working with TipRanks
Follow Us
Vivimed Labs Limited (IN:VIVIMEDLAB)
:VIVIMEDLAB
Total Valuation
Vivimed Labs Limited has a market cap or net worth of $406.28M. The enterprise value is $4.17B.
Market Cap$406.28M
Enterprise Value$4.17B
Share Statistics
Vivimed Labs Limited has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vivimed Labs Limited’s return on equity (ROE) is 0.91 and return on invested capital (ROIC) is -4.05%.
Return on Equity (ROE)0.91
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-4.05%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee1.92M
Profits Per Employee-526.54K
Employee Count607
Asset Turnover0.13
Inventory Turnover1.85
Valuation Ratios
The current PE Ratio of Vivimed Labs Limited is -1.29. Vivimed Labs Limited’s PEG ratio is 0.03.
PE Ratio-1.29
PS Ratio―
PB Ratio-1.17
Price to Fair Value-1.17
Price to FCF4.36
Price to Operating Cash Flow4.37
PEG Ratio0.03
Income Statement
In the last 12 months, Vivimed Labs Limited had revenue of 1.16B and earned -319.61M in profits. Earnings per share was -3.85.
Revenue1.16B
Gross Profit77.98M
Operating Income-332.72M
Pretax Income-318.48M
Net Income-319.61M
EBITDA-86.77M
Earnings Per Share (EPS)-3.85
Cash Flow
In the last 12 months, operating cash flow was 188.16M and capital expenditures 0.00, giving a free cash flow of 188.16M billion.
Operating Cash Flow188.16M
Free Cash Flow188.16M
Free Cash Flow per Share―
Dividends & Yields
Vivimed Labs Limited pays an annual dividend of $0.4, resulting in a dividend yield of ―
Dividend Per Share$0.4
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Vivimed Labs Limited upcoming earnings date is Aug 8, 2025, TBA (Confirmed).
Last Earnings DateFeb 14, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateSep 19, 2018
Financial Position
Vivimed Labs Limited as a current ratio of 0.80, with Debt / Equity ratio of -1070.06%
Current Ratio0.80
Quick Ratio0.66
Debt to Market Cap9.16
Net Debt to EBITDA-43.29
Interest Coverage Ratio-11.29
Taxes
In the past 12 months, Vivimed Labs Limited has paid 1.13M in taxes.
Income Tax1.13M
Effective Tax Rate>-0.01
Enterprise Valuation
Vivimed Labs Limited EV to EBITDA ratio is -48.02, with an EV/FCF ratio of -48.30.
EV to Sales3.58
EV to EBITDA-48.02
EV to Free Cash Flow-48.30
EV to Operating Cash Flow-101.71
Balance Sheet
Vivimed Labs Limited has $16.26M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -$16.26M billion.
Cash & Marketable Securities$16.26M
Total Debt₹0.00
Net Cash-$16.26M
Net Cash Per Share―
Tangible Book Value Per Share-$4.24
Margins
Gross margin is 36.23%, with operating margin of -28.62%, and net profit margin of -27.49%.
Gross Margin36.23%
Operating Margin-28.62%
Pretax Margin-27.39%
Net Profit Margin-27.49%
EBITDA Margin-7.46%
EBIT Margin-24.86%
Analyst Forecast
The average price target for Vivimed Labs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―